NanoVation Therapeutics logo

NanoVation Therapeutics

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

Undisclosed


NanoVation Therapeutics develops lipid nanoparticle technology for RNA delivery to cells, focusing on genetic medicines for cardiometabolic and rare diseases.

Total Funding

Undisclosed

Headquarters

Vancouver, Canada

Founded

N/A

Focus Areas

Lipid nanoparticles
RNA delivery
genetic medicines
cardiometabolic diseases
rare diseases
nucleic acid delivery.

Investors

Convergent Ventures logo